
TV shows to tackle amblyopia
Digital therapeutics company Luminopia has received the US Food and Drug Administration’s (FDA) De Novo premarket approval for Luminopia One, which uses TV shows to improve vision in children with
4295 articles

Digital therapeutics company Luminopia has received the US Food and Drug Administration’s (FDA) De Novo premarket approval for Luminopia One, which uses TV shows to improve vision in children with

A GP screening diabetic patients using oDocs Eye Care’s Nun ophthalmoscope diagnosed diabetic retinopathy (DR) with 90% sensitivity and diabetic macular oedema (DMO) with 20% sensitivity. Led by Dr

A US study has found that the prevalence of endophthalmitis following minimally invasive glaucoma surgery (MIGS) is similar to the reported incidences of endophthalmitis after other incisional

The following is a special Covid-19 update from the Optometrists and Dispensing Opticians Board (ODOB) 1 December 2021: Tēnā koe As you are aware, Aotearoa New Zealand moves to the Covid-19

The Optometrists and Dispensing Opticians Board (ODOB) has appointed Elmarie Stander as its new registrar. Stander’s experience includes policy and advocacy work, both from the Australasian College for Emergency Medicine, where she managed its Aotearoa office, and from the New Zealand Qualifications

Insurance broker Crombie Lockwood has partnered with CMI Optical to offer New Zealand practices and optometry supply businesses a lower-cost, optometry-specific insurance policy.

Lumenis showcased its new OptiLight technology for the treatment of dry eye disease (DED) to the Australian and New Zealand market at a recent virtual event, sharing insights into its application for clinics and their patients.

Maison Jean-François Rey’s Volte Face’s fall/winter 2021 collection offers a stunning selection of 14 models featuring vibrant colours rendered in acetate. The styles include assertive shapes,

Two pairs of extraordinary spectacles with diamond and emerald lenses, once owned by an unknown Mughal prince in South Asia, failed to find a buyer at Sotheby’s October 2021 auction.

US-based Aldeyra Therapeutics announced it’s 0.25% reproxalap ophthalmic solution met its primary endpoint in a phase 2 clinical trial in dry eye disease (DED) patients. Of the 158 patients enrolled

Kenmark Eyewear has partnered with Eastman to create ISCC-certified eyewear using Acetate Renew, which the companies said will help keep plastic waste out of landfills and reduce fossil fuel

The following is a special Covid-19 update from the Optometrists and Dispensing Opticians Board (ODOB) 19 November 2021: Tēnā koe, Firstly, we would like to thank all practitioners for following the